The authorization from Health Canada was based upon the safety and efficacy results of two large, randomized pivotal Phase III special protocol assessment trials, North American trial MM-009
The compound is being developed as a new and potentially safer means of targeting phosphodiesterase 4 (PDE4) to combat memory loss and cognitive deficits associated with Alzheimer’s disease
Laborie Medical Technologies said that it has been actively marketing T-DOC products with its urodynamics systems for several years in North America. T-DOC, along with Laborie’s line of
In her new role as president of Cell Therapeutics (CTI) Europe, Dr Waters, will accelerate the launch of Ap(3)ana, an organization that will seek to integrate new technologies
With this order, Sectra will replace existing systems at the university hospitals in Malmo and Lund. The initial order value amounts to SEK30 million. The use of Sectra’s
Ira Goldknopf, president and chief scientific officer of Power3, said: “Power3 Medical is preparing to commercialize its BC SeraPro, and NuroPro tests for breast cancer, Alzheimer’s and Parkinson’s.
Natus has acquired all outstanding shares of NeuroCom capital stock for $18 million, exclusive of direct costs of the acquisition. Natus believes that the acquisition will be immediately
Dr Schafer is currently vice president of the Ultrasonic Industry Association, chairman of the National Electrical Manufacturers Association Ultrasound Technical Committee, and serves on the board of governors
Under the terms of the agreement, Lilly and Deciphera will collaborate in four different project areas involving selective or multi-kinase targeted B-Raf inhibitors. Lilly will obtain exclusive worldwide
The Lifepak 20e defibrillator/monitor offers all the capabilities of the Lifepak 20 device, along with a lithium-ion battery that doubles ECG monitoring time and the run time of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.